Management of adolescent confidentiality and sensitive services has always posed challenges to medical clinicians. State and federal laws, as well as institutional policies, may dictate what information can or cannot be shared by a clinician with a parent or guardian of an adolescent. Clinicians concerned about diagnosis disclosure via insurance notifications may limit their testing or prescription, refer sensitive services to more specialized reproductive health clinics, or appeal to non-insurance funders to cover sensitive testing and confidential prescriptions. All factors may be burdensome to patients, families, and/or clinicians.
top of page
Search
Recent Posts
See Allhttps://www.nytimes.com/2020/03/27/podcasts/the-daily/kids-coronavirus.html?rref=vanity What is a virus? What does COVID-19 do to your...
80
https://pediatrics.aappublications.org/content/early/2020/01/07/peds.2019-1324 Family Partnership articles reflect the joint perspective...
120
https://pediatrics.aappublications.org/content/early/2020/01/21/peds.2019-1725 BACKGROUND AND OBJECTIVES: Gonadotropin-releasing hormone...
130
bottom of page
Yorumlar